Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1991 Sep;82(9):1035–1043. doi: 10.1111/j.1349-7006.1991.tb01940.x

Characterization of an Etoposide‐resistant Human K562 Cell Line, K/eto

Isamu Sugawara 1,✉, Toshiro Iwahashi 2, Kazuya Okamoto 3, Yoshikazu Sugimoto 4, Hisao Ekimoto 3, Takashi Tsuruo 5, Tatsuro Ikeuchi 6, Shigeo Mori 2
PMCID: PMC5918605  PMID: 1657846

Abstract

An etoposide‐resistant K562 cell line (K/eto) was obtained by stepwise exposure, in culture, to increasing concentrations of etoposide, without the use of mutagens. This cell line was resistant to etoposide, and slightly resistant to adriamycin, but sensitive to anti‐cancer drugs such as camptothecin, vincristine, actinomycin D and so on. P‐GIycoprotein, the mdr1 gene product, was not detected in this cell line, as assessed by immunocytochemistry, itnmunoprecipitation and flow cytometry. Overexpression of mdr1 mRNA was also not found. Interestingly, expression of 85 kD protein recognized by MRK 20 monoclonal antibody was noted. The level of DNA topoisomerase II protein, detected by antibody staining, decreased concomitantly with a general decrease in DNA topoisomerase II unknotting activity, while DNA topoisomerase I activity was not affected. Cellular accumulation of [3H]etoposide was reduced by 75% in the resistant line compared with parental K562. Karyotype analysis showed that the number of chromosomes in K/eto was 55 and neither a homogeneous staining region nor double‐minute chromosomes were detected. These results indicate that this resistance is not due to an altered interaction between the drug and cellular transport machinery, i.e. MDR1, associated with the “classic” multiple drug resistance phenotype, but rather is due to the existence of other mechanism(s) of resistance, decreased transport of the drug and decreased target enzyme, DNA topoisomerase II.

Keywords: Etoposide, Multidrug resistance, K562, 85 kD protein, DNA topoisomerase II

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

REFERENCES

  • 1. ) Pastan , I. and Gottesman , M.Multiple‐drug resistance in human cancer . N. Engl. J. Med. , 316 , 1388 – 1393 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Long , B. H. and Stringfellow , D. A.Inhibitors of topoisomerase II: structure‐activity relationships and mechanism of action of podophyllin congeners . Adv. Enzyme Regul. , 27 , 223 – 256 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Danks , M. K. , Yalowich , J. C. and Beck , W. T.Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM‐26) , Cancer Res. , 47 , 1297 – 1301 ( 1987. ). [PubMed] [Google Scholar]
  • 4. ) Hill , B. T. and Whelan , R. D. H.Establishment of vincristine‐resistant and vindesine‐resistant lines of murine lymphoblasts in vitro and characterization of their patterns of cross‐resistance and drug sensitivities . Cancer Cliemother. Pharmacol , 8 , 163 – 169 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Glisson , B. , Gupta , R. , Smallwood‐Kentro , S. and Ross , W.Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug‐stimulated DNA cleavage activity . Cancer Res. , 46 , 1934 – 1938 ( 1986. ). [PubMed] [Google Scholar]
  • 6. ) Johnson , R. K. and Howard , R. S.Development and cross‐resistance characteristics of a subline of P388 leukemia resistant to 4′‐(9‐acridinylatnino)methanesulfonyl‐m‐anisidine . Eur. J. Clin. Oncol. , 18 , 479 – 487 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Gupta , R. S.Genetic, biochemical, and cross‐resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM‐26 and VP‐16‐213 . Cancer Res. , 43 , 1568 – 1574 ( 1983. ). [PubMed] [Google Scholar]
  • 8. ) Odaimi , M. , Andersson , B. S. , McCredie , K. B. and Beran , M.Drug sensitivity and cross‐resistance of the 4′‐(9‐acridinylamino)methanesulfonyl‐m‐anisidine‐resistant subline of HL‐60 human leukemia . Cancer Res. , 46 , 3330 – 3333 ( 1986. ). [PubMed] [Google Scholar]
  • 9. ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Oh‐hara , T. , Hamada , H. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones . Jpn. J. Cancer Res. , 77 , 682 – 692 ( 1986. ). [PubMed] [Google Scholar]
  • 10. ) Lozzio , C. B. and Lozzio , B. B.Human chronic myelogenous leukemia cell line with positive Philadelphia chromosomes . Blood , 45 , 321 – 328 ( 1975. ). [PubMed] [Google Scholar]
  • 11. ) Akiyama , S. , Fojo , A. , Hanover , J. A. , Pastan , I. and Gottesman , M. M.Isolation and genetic characterization of human KB cell lines resistant to multiple drugs . Somatic Cell Mol. Genet. , 11 , 117 – 126 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Shen , D. W. , Fojo , A. , Chin , J. E. , Roninson , I. B. , Richert , N. , Pastan , I. and Gottesman , M. M.Human multidrug resistant cell lines: increased mdr1 expression can precede gene amplification . Science , 232 , 643 – 645 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Hamada , H. and Tsuruo , T.Functional role for the 170‐to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Hamada , H , Okochi , E. , Watanabe , M. , Oh‐hara , T , Sugimoto , Y. , Kawabata , H. and Tsuruo , T. , Mr.85,000 membrane protein specifically expressed in adriamycin. resistant human tumor cells . Cancer Res. , 48 , 7082 – 7087 ( 1988. ). [PubMed] [Google Scholar]
  • 15. ) Halligan , B. D. , Edwards , K. A. G. and Liu , L. F.Purification and characterization of a type II DNA topoisomerase from bovine calf thymus . J. Biol. Chem. , 260 , 2475 – 2482G ( 1985. ). [PubMed] [Google Scholar]
  • 16. ) Ferguson , P. J. , Fisher , M. H. , Stephenson , J. , Li , D‐H. , Zhou , B‐S. and Cheng , Y‐C.Combined modalities of resistance in etoposide‐resistant human KB cell lines . Cancer Res. , 48 , 5956 – 5964 ( 1988. ). [PubMed] [Google Scholar]
  • 17. ) Fukuhara , S. and Rowley , J. D.Chromosome 14 trans‐locations in non‐Burkitt lymphomas . Int. J. Cancer , 22 , 14 – 21 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Sugawara , I. , Kataoka , L , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multidrug‐resistant gene as revealed by a monoclonal antibody, MRK 16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). [PubMed] [Google Scholar]
  • 19. ) Sugawara , I. , Ohkochi , E. , Hamada , H. , Tsuruo , T. and Mori , S.Cellular and tissue distribution of MRK20 murine monoclonal antibody‐defined 85‐kDa protein in adriamycin‐resistant cancer cell lines . Jpn. J. Cancer Res. , 79 , 1101 – 1110 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Miller , K. G. , Liu , L. F. and Englund , P. T.A homogeneous type II DNA topoisomerase from HeLa cell nuclei . J. Biol. Chem. , 256 , 9334 – 9339 ( 1981. ). [PubMed] [Google Scholar]
  • 21. ) Hamada , H. and Tsuruo , T.Growth inhibition of multidrug‐resistant cells by monoclonal antibodies against P‐glycoprotein . In “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells ,” ed. Roninson I. ( 1991. ). Plenum Press; , New York , ( in press ). [Google Scholar]
  • 22. ) Sugawara , I. , Nakahama , M. , Hamada , H. , Tsuruo , T. and Mori , S.Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000‐180,000 P‐glycoprotein . Cancer Res. , 48 , 4611 – 4614 ( 1988. ). [PubMed] [Google Scholar]
  • 23. ) Maniatis , T. , Fritsch , E. F. and Sambrook , J. “ Molecular Cloning: A Laboratory Manual ” ( 1982. ). Cold Spring Harbor Laboratories; , Cold Spring Harbor , NY . [Google Scholar]
  • 24. ) Gussow , D. , Rein , R. , Ginjaar , L , Hochsteinbach , F. , Seemann , G. , Kottman , A. and Ploegh , H. L.The human β2‐microglobulin gene primary structure and definition of the transcription unit . J. Immunol. , 139 , 3132 – 3138 ( 1987. ). [PubMed] [Google Scholar]
  • 25. ) Ueda , K. , Cardarelli , C. , Gottesman , M. M. and Pastan , I.Expression of a full‐length cDNA for the human mdr1 (P‐glycoprotein) gene confers multidrug‐resistance . Proc. Natl. Acad. Sci. USA , 84 , 3004 – 3008 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Noonan , K. E. and Roninson , I. B.mRNA phenotyping by enzymatic amplification of randomly primed cDNA . Nucleic Acids Res. , 16 , 10366 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Deffie , A. M. , Batra , J. K. and Goldenberg , G. J.Direct correlation between DNA topoisomerase II activity and cytotoxicity in Adriamycin‐sensitive and ‐resistant P388 leukemia cell lines . Cancer Res. , 49 , 58 – 62 ( 1989. ). [PubMed] [Google Scholar]
  • 28. ) Danks , M. K. , Schmidt , C. A. , Cirtain , M. C. , Suttle , D. P. and Beck , W. T.Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemia cells selected for resistance to VM‐26 . Biochemistry , 27 , 8861 – 8869 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Sullivan , D. M. , Latham , M. D. , Row , T. C. and Ross , W. E.Purification and characterization of an altered topoisomerase II from a drug‐resistant Chinese hamster ovary cell line . Biochemistry , 28 , 5680 – 5687 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Beck , W. T. , Cirtain , M. C. , Danks , M. K. , Felsted , R. L. , Safa , A. R. , Wolverton , J. S. , Suttle , D. P. and Trent , J. M.Pharmacological, molecular, and cytogenetic analysis of “atypical” multidrug‐resistant human leukemic cells . Cancer Res. , 47 , 5455 – 5460 ( 1987. ). [PubMed] [Google Scholar]
  • 31. ) Kartner , N. , Evernden‐Porelle , D. , Bradley , G. and Ling , V.Detection of P‐glycoprotein in multidrug‐resistant cell lines by monoclonal antibodies . Nature , 316 , 820 – 823 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Center , M. S.Mechanisms regulating cell resistance to Adriamycin. Evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein . Biochem. Pharmacol. , 34 , 1471 – 1476 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Peterson , R. H. F. , Meyers , M. B. , Spengler , B. A. and Biedler , J. L.Alteration of plasma membrane glyco‐peptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine . Cancer Res. , 43 , 222 – 228 ( 1983. ). [PubMed] [Google Scholar]
  • 34. ) Beck , W. T. , Mueller , T. J. and Tanzer , L. R.Altered surface membrane glycoproteins in Vinca alkaloid‐resistant human leukemic lymphoblasts . Cancer Res. , 39 , 2070 – 2076 ( 1979. ). [PubMed] [Google Scholar]
  • 35. ) Riordan , J. R. and Ling , V.Purification of P‐glycoprotein from plasma membranes vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability . J. Biol. Chem. , 254 , 12701 – 12705 ( 1979. ). [PubMed] [Google Scholar]
  • 36. ) Shen , D‐W. , Cardarelli , C. , Hwang , J. , Cornell , M , Richert , N. , Ishii , S. , Pastan , I. and Gottesman , M. M.Multiple drug‐reistant human KB carcinoma cells independently selected for high‐level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins . J. Biol. Chem. , 261 , 7762 – 7770 ( 1986. ). [PubMed] [Google Scholar]
  • 37. ) Danks , M. K. , Metzger , D. W. , Ashmun , R. A. and Beck , W. T.Monoclonal antibodies to glycoproteins of Vinca alkaloid‐resistant human leukemic cells . Cancer Res. , 45 , 3220 – 3224 ( 1985. ). [PubMed] [Google Scholar]
  • 38. ) Yanovich , S. , Hall , R. E. and Gewirtz , D. A.Characterization of a K562 multidrug‐resistant cell line . Cancer Res. , 49 , 4499 – 4503 ( 1989. ). [PubMed] [Google Scholar]
  • 39. ) Mirski , S. E. L. and Cole , S. P. C.Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line . Cancer Res. , 49 , 5719 – 5724 ( 1989. ). [PubMed] [Google Scholar]
  • 40. ) Matsuo , K. , Kohno , K. , Takano , H. , Sato , S. , Kiue , A. and Kuwano , M.Reduction of drug accumulation and DNA topoisomerase II activity in acquired Teniposideresistant human KB cell lines . Cancer Res. , 50 , 5819 – 5824 ( 1990. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES